Sopharma SA
1.5 FTESopharma reported total assets of €172.1m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026), with 1.5 full-time equivalent.
The score of Sopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +225 % Total assets +228 % Headcount (avg FTE) -40 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 26 May 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 14 Jun 2023
- Year ended 31 Dec 2021filed on 30 Sep 2022
Sopharma's financial analysis
- Solvency97.2%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sopharma
Sopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.391.546
- VAT number
- BE0476391546
- Peppol
- Registered · 0208:0476391546 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Dec 2001
- Registered office
- 3080 Tervuren
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sopharma (SA) has been based in Tervuren since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of €14.3m and equity of €167.3m; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 97.2%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sopharma
Companies in the same business, of comparable size and area, outside its group.
- AHDS Activities of holding companies Ixelles · balance sheet €128.2m
- Condor Holdco Activities of holding companies Brussels · balance sheet €156.8m
- NEO Gema Activities of holding companies Brussels · balance sheet €212.9m
- Blue Sea Holding Activities of head offices Saint-Josse-ten-Noode · balance sheet €123.4m
- Ideal Group Business and other management consultancy activities Wielsbeke · balance sheet €232.8m
- Oddo BHF Belgium Activities of holding companies Ixelles · balance sheet €335.0m
- Cheops Capital Partners Activities of holding companies Kontich · balance sheet €56.2m
- Straco Investments Activities of holding companies Waasmunster · balance sheet €519.4m
Frequently asked questions about Sopharma
What is the revenue of Sopharma?
Sopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0476391546 for Sopharma, if the company is VAT-registered. Its company number (CBE) is 0476.391.546.
Where is the registered office of Sopharma?
According to the CBE register, the registered office of Sopharma is in 3080 Tervuren.
What is the equity of Sopharma?
At the close of the 2025 financial year, the equity of Sopharma amounts to 167,332,901 €, a solvency of 97.2% of total assets.
How many people work at Sopharma?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sopharma?
The register lists 3 active mandates at Sopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →